Exchange: NYSE
Industry: Pharmaceuticals & Biotechnology
Last Trade: 4:00 PM ET 4/5/2013
Last 10 Quotes:
What's This?
Find a Broker »
- li>
- li>
- li>
- li>
- li>
| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | 0.13 | -0.32 | -142.13 |
| EPS, GAAP | 0.03 | -1.29 | -1.29 |
| Consensus Estimate | 0.54 | 0.47 | 15.98 |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | 0.66 | 1.80 | -63.08 |
| EPS, GAAP | 0.27 | -0.06 | -568.80 |
| Consensus Estimate | 2.00 | 3.90 | -48.72 |
| HSP | Industry Average | |
| P/E (TTM) | 117.88 | NA |
| P/E (Forward) | 15.09 | NA |
| PEG Ratio | 2.01 | 2.20 |
| Price/Sales | 1.24 | 18.91 |
| Beta | 0.67 | 0.70 |
| 3/25/2013 | Top Analyst Upgrades and Downgrades (ARG, ALL, BBRY, CEO, CMCSA, FINL, HSP, JCP, LIFE, RBS, SYW, SIAL, SPW, WFM) (24/7 Wall St) |
| 2/26/2013 | Copies of Costly Biotech Drugs Face Delays (WSJ.com) |
| 2/14/2013 | Hospira Falls 8% After FDA Action (Barrons.com) |
| 2/11/2013 | Stocks Fall; Novo Nordisk, Tesla Shares Drop (Barrons.com) |
| 2/9/2013 | This Weekend's Barron's: Annual Barron's/Lipper Fund Family Rankings ~ Dell Deal May Die ~ Cashing in on Capex ~ Positive Feedback for Wendy's Could Boost Its Shares (Barrons.com) |
| 2/9/2013 | Off the Critical List and Onto the Buy List (Barrons.com) |
| 2/6/2013 | Give Hospira a Shot (Barrons.com) |
| 1/9/2013 | Stocks Close Up; Ruby Tuesday Falling (Barrons.com) |